Literature DB >> 17460556

Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation.

Mary Amanda Dew1, Andrea F DiMartini, Annette De Vito Dabbs, Larissa Myaskovsky, Jennifer Steel, Mark Unruh, Galen E Switzer, Rachelle Zomak, Robert L Kormos, Joel B Greenhouse.   

Abstract

BACKGROUND: Despite the impact of medical regimen nonadherence on health outcomes after organ transplantation, there is mixed and conflicting evidence regarding the prevalence and predictors of posttransplant nonadherence. Clinicians require precise information on nonadherence rates in order to evaluate patients' risks for this problem.
METHODS: A total of 147 studies of kidney, heart, liver, pancreas/kidney-pancreas, or lung/heart-lung recipients published between 1981 and 2005 were included in a meta-analysis. Average nonadherence rates were calculated for 10 areas of the medical regimen. Correlations between nonadherence and patient psychosocial risk factors were examined.
RESULTS: Across all types of transplantation, average nonadherence rates ranged from 1 to 4 cases per 100 patients per year (PPY) for substance use (tobacco, alcohol, illicit drugs), to 19 to 25 cases per 100 PPY for nonadherence to immunosuppressants, diet, exercise, and other healthcare requirements. Rates varied significantly by transplant type in two areas: immunosuppressant nonadherence was highest in kidney recipients (36 cases per 100 PPY vs. 7 to 15 cases in other recipients). Failure to exercise was highest in heart recipients (34 cases per 100 PPY vs. 9 to 22 cases in other recipients). Demographics, social support, and perceived health showed little correlation with nonadherence. Pretransplant substance use predicted posttransplant use.
CONCLUSIONS: The estimated nonadherence rates, overall and by transplant type, allow clinicians to gauge patient risk and target resources accordingly. Nonadherence rates in some areas--including immunosuppressant use--appear unacceptably high. Weak correlations of most patient psychosocial factors with nonadherence suggest that attention should focus on other classes of variables (e.g., provider-related and systems-level factors), which may be more influential.

Entities:  

Mesh:

Year:  2007        PMID: 17460556     DOI: 10.1097/01.tp.0000258599.65257.a6

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  137 in total

Review 1.  Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

Authors:  Mary B Prendergast; Robert S Gaston
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

2.  Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients.

Authors:  Cynthia Russell; Vicki Conn; Catherine Ashbaugh; Richard Madsen; Mark Wakefield; Andrew Webb; Deanna Coffey; Leanne Peace
Journal:  Clin Transplant       Date:  2010-11-16       Impact factor: 2.863

Review 3.  Medical adherence in pediatric organ transplantation: what are the next steps?

Authors:  Diana A Shellmer; Annette DeVito Dabbs; Mary Amanda Dew
Journal:  Curr Opin Organ Transplant       Date:  2011-10       Impact factor: 2.640

Review 4.  Psychosocial Challenges in Solid Organ Transplantation.

Authors:  Kristin Kuntz; Stephan R Weinland; Zeeshan Butt
Journal:  J Clin Psychol Med Settings       Date:  2015-09

5.  Team-Based Biopsychosocial Care in Solid Organ Transplantation.

Authors:  Jared Lyon Skillings; Amber N Lewandowski
Journal:  J Clin Psychol Med Settings       Date:  2015-09

6.  Long-Term Follow-up of a Randomized Controlled Trial Evaluating a Mobile Health Intervention for Self-Management in Lung Transplant Recipients.

Authors:  E M Rosenberger; A J DeVito Dabbs; A F DiMartini; D P Landsittel; J M Pilewski; M A Dew
Journal:  Am J Transplant       Date:  2016-10-31       Impact factor: 8.086

7.  Using mobile health technology to deliver decision support for self-monitoring after lung transplantation.

Authors:  Yun Jiang; Susan M Sereika; Annette DeVito Dabbs; Steven M Handler; Elizabeth A Schlenk
Journal:  Int J Med Inform       Date:  2016-07-19       Impact factor: 4.046

8.  Time-in-a-bottle (TIAB): a longitudinal, correlational study of patterns, potential predictors, and outcomes of immunosuppressive medication adherence in adult kidney transplant recipients.

Authors:  Cynthia L Russell; Catherine Ashbaugh; Leanne Peace; Muammer Cetingok; Karen Q Hamburger; Sarah Owens; Deanna Coffey; Andrew W Webb; Donna Hathaway; Rebecca P Winsett; Richard Madsen; Mark R Wakefield
Journal:  Clin Transplant       Date:  2013 Sep-Oct       Impact factor: 2.863

9.  Lung transplantation for cystic fibrosis.

Authors:  Frederick R Adler; Paul Aurora; David H Barker; Mark L Barr; Laura S Blackwell; Otto H Bosma; Samuel Brown; D R Cox; Judy L Jensen; Geoffrey Kurland; George D Nossent; Alexandra L Quittner; Walter M Robinson; Sandy L Romero; Helen Spencer; Stuart C Sweet; Wim van der Bij; J Vermeulen; Erik A M Verschuuren; Elianne J L E Vrijlandt; William Walsh; Marlyn S Woo; Theodore G Liou
Journal:  Proc Am Thorac Soc       Date:  2009-12

Review 10.  Adherence to immunosuppressive therapy following liver transplantation: an integrative review.

Authors:  Ramon Antônio Oliveira; Ruth Natália Teresa Turrini; Vanessa de Brito Poveda
Journal:  Rev Lat Am Enfermagem       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.